Media Coverage & Publications: Kyoto Shimbun DIGITAL, Yomiuri Shimbun Online, Regional Newspapers, BRIDGE, and Medical Journal Contribution

Rege Nephro Co., Ltd. ("Rege Nephro") is pleased to announce recent media coverage featuring our company, as well as our contribution to a medical journal, as detailed below.

• [Article] Kyoto Shimbun DIGITAL "Kyoto University Spin-off Aims for 'Innovative' Kidney Disease Treatment: 'Creating a World Without the Need for Dialysis'"
  https://www.kyoto-np.co.jp/articles/-/1788699 (only in Japanese)
• [Article] Regional Newspapers Our initiatives in treating kidney diseases using iPS cell technology were featured across various regional newspapers.　Featured Outlets: Shinano Mainichi Shimbun, The Tō-Ō Nippō, Kumamoto Nichinichi Shimbun, Chubu Keizai Shimbun, Oita Godo Shimbun, Saitama Shimbun
• [Article] The Yomiuri Shimbun, Osaka Edition / Yomiuri Shimbun Online
  "'We Will Create the Global Market'… Kansai Leads the 'Future of Medicine' Showcased at the Expo, Ranked Third Globally; Technologies Include Assessing Breast Cancer Risk from Tears"
  https://www.yomiuri.co.jp/expo2025/20261009-GYO1T00133 (only in Japanese)
• [Article] BRIDGE "Promising iPS Venture ReGenePhro Raises ¥1.7B via J-KISS with Unique Biotech Startup Support"
  https://thebridge.jp/2026/11/deeptech-finance-regenephro-2 (only in Japanese)
• [Publication] Journal of Clinical and Experimental Medicine (Igaku no Ayumi), Vol. 299 An article co-authored by our researcher, Hiraku Tsujimoto, titled "New Developments in Regenerative Medicine for Chronic Kidney Disease Pioneered by iPS Cell Technology," has been published.

Media Inquiries:
Mariko Iwamura
Rege Nephro Co., Ltd.
E-mail: [email protected]